Attenuated response of myocardial flow reserve to lipid-lowering therapy with atorvastatin in patients with familial hypercholesterolemia.

被引：0
|
作者：
Ishida, Y
Tsushima, M
Fukuchi, K
Miyake, Y
Sagoh, M
Oka, H
机构：
[1] Natl Cardiovasc Ctr, Dept Radiol & Nucl Med, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Dept Cardiol, Suita, Osaka 565, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
171
引用
收藏
页码：54P / 54P
页数：1
相关论文
共 50 条
  • [31] LIFIBROL - A NOVEL LIPID-LOWERING DRUG FOR THE THERAPY OF HYPERCHOLESTEROLEMIA
    LOCKER, PK
    JUNGBLUTH, GL
    FRANCOM, SF
    HUGHES, GS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (01) : 73 - 88
  • [32] Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy
    Marco-Benedi, Victoria
    Laclaustra, Martin
    Casado-Dominguez, Juan M.
    Villa-Pobo, Rosa
    Mateo-Gallego, Rocio
    Sanchez-Hernandez, Rosa M.
    Blanco Nuez, Marta
    Ortega-Martinez de Victoria, Emilio
    Sitges, Marta
    Pedro-Botet, Juan
    Puzo, Jose
    Villarroel, Teresa
    Civeira, Fernando
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [33] Case Report: Cardiac Surgery and Combined Lipid-Lowering Drug Therapy for Homozygous Familial Hypercholesterolemia
    Gao, Mingxin
    Yu, Wenyuan
    Hu, Hui
    Liu, Hongli
    Fan, Kangjun
    Gu, Chengxiong
    Wang, Lvya
    Yu, Yang
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [34] Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
    Yamashita, Shizuya
    Masuda, Daisaku
    Harada-Shiba, Mariko
    Arai, Hidenori
    Bujo, Hideaki
    Ishibashi, Shun
    Daida, Hiroyuki
    Koga, Nobuhiko
    Oikawa, Shinichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (05) : 608 - 638
  • [35] Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
    Perez-Calahorra, Sofia
    Laclaustra, Martin
    Marco-Benedi, Victoria
    Lamiquiz-Moneo, Itziar
    Pedro-Botet, Juan
    Plana, Nuria
    Sanchez-Hernandez, Rosa M.
    Amor, Antonio J.
    Almagro, Fatima
    Fuentes, Francisco
    Suarez-Tembra, Manuel
    Civeira, Fernando
    ATHEROSCLEROSIS, 2019, 284 : 245 - 252
  • [36] Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram
    Nemes, A
    Neu, K
    Forster, T
    Gruber, N
    Csanády, M
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2004, 21 (01): : 37 - 41
  • [37] Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia
    Izar, M. C.
    Machado, V. A.
    Fonseca, H. A.
    Fonseca, F. A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 285 - 285
  • [38] Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia
    Machado, Valeria A.
    Fonseca, Francisco A.
    Fonseca, Henrique A.
    Malina, Daniela T.
    Fonzar, Waleria T.
    Barbosa, Silvio A.
    Santana, Jose M.
    Izar, Maria C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 570 - 572
  • [39] Lomitapide and Mipomersen Novel Lipid-Lowering Agents for the Management of Familial Hypercholesterolemia
    Dixon, Dave L.
    Sisson, Evan M.
    Butler, Michael
    Higbea, Ashley
    Muoio, Brendan
    Turner, Brandy
    JOURNAL OF CARDIOVASCULAR NURSING, 2014, 29 (05) : E7 - E12
  • [40] Heterogeneity of response to lipid-lowering therapy
    Bach, RG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 2136 - 2137
12345